Hepatology

The risk of MASLD increases following menopause before the age of 50, according to a 2026 global cohort study.

Combining AI-processed CECT with clinical data improves the management of unresectable hepatocellular carcinoma, a 2026 study has found.

New data suggest MASLD overlap alters pruritus and fatigue severity in primary sclerosing cholangitis, with implications for symptom monitoring in hepatology practice.

Novel non-invasive liver disease assessments (NILDAs) are effective liver biopsy alternatives for fibrosis, a 2026 systematic review has found.

Matched targeted treatment significantly improved overall survival in advanced cholangiocarcinoma in the Italian ANITA real-world dataset.

New study shows age predicts six-week mortality in cirrhotic patients after acute gastrointestinal bleeding, with potential to improve risk stratification.

New research shows that bacteria normally found in the mouth can travel to the gut and promote liver scarring by damaging the gut barrier.

A global report shows uneven progress toward WHO hepatitis elimination goals, highlighting persistent policy and implementation gaps in testing and treatment.